28 results on '"Verheijen J"'
Search Results
2. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3
3. CARTILAGE DEGRADATION AND INVASION BY RHEUMATOID SYNOVIAL FIBROBLASTS IS INHIBITED BY GENE TRANSFER OF A CELL SURFACE–TARGETED PLASMIN INHIBITOR
4. Assignment of the human tissue-type plasminogen activator gene (PLAT) to chromosome 8
5. Zur Lebensweise der Kuckucke von Flores
6. Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients.
7. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms.
8. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.
9. Oral matrix metalloproteinase inhibition and arterial remodeling after balloon dilation: an intravascular ultrasound study in the pig.
10. Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: a study in the atherosclerotic Yucatan micropig.
11. MMP-9 Activity in Urine from Patients with Various Tumors, as Measured by a Novel MMP Activity Assay Using Modified Urokinase as a Substrate.
12. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces.
13. Plasminogen Activators and Gastrointestinal Neoplasms.
14. Prognostic value of the plasminogen activation system in patients with gastric carcinoma.
15. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma.
16. Indicators of depressed fibrinolytic activity in pre-operative prediction of deep venous thrombosis.
17. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.
18. DIFFERENCE IN EXPRESSION OF THE PLASMINOGEN ACTIVATION SYSTEM IN SYNOVIAL TISSUE OF PATIENTS WITH RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS.
19. Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor.
20. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
21. Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.
22. Thrombolytic Properties in a Rabbit Jugular Vein Thrombosis Model of a Tissue-type Plasminogen Activator Mutant Lacking the Growth Factor- and Kringle 1-Domains.
23. Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy.
24. 2-5A-PNA Complexes: A Novel Class of Antisense Compounds.
25. Fibrinogen and atherosclerosis: a study in transgenic mice
26. Properties of metastasizing and non-metastasizing human melanoma cell lines.
27. ChemInform Abstract: Use of Furanoid Glycals in Oligosaccharide Synthesis.
28. ChemInform Abstract: Rhodium(II)-Catalyzed Asymmetric Cyclopropanation of Glycals with Ethyl Diazoacetate.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.